Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 | Clinical Cancer Drugs | journal | 0.105 Q4 | 4 | 1 | 5 | 57 | 0 | 5 | 0.00 | 57.00 | 25.00 | |
99 | Open Breast Cancer Journal | journal | 0.113 Q4 | 5 | 0 | 6 | 0 | 2 | 6 | 0.00 | 0.00 | 0.00 | |
98 | Gaceta Mexicana de Oncologia | journal | 0.119 Q4 | 7 | 67 | 174 | 1500 | 15 | 159 | 0.05 | 22.39 | 37.00 | |
97 | Open Cancer Immunology Journal | journal | 0.123 Q4 | 4 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
96 | Cancer Metastasis - Biology and Treatment | book series | 0.136 Q4 | 6 | 0 | 38 | 0 | 4 | 37 | 0.11 | 0.00 | 0.00 | |
95 | Open Cancer Journal | journal | 0.137 Q4 | 7 | 0 | 7 | 0 | 2 | 7 | 0.17 | 0.00 | 0.00 | |
94 | Cancer Treatment and Research Communications | journal | 0.182 Q4 | 23 | 57 | 65 | 1455 | 22 | 65 | 0.37 | 25.53 | 32.29 | |
93 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.242 Q4 | 50 | 11 | 63 | 2385 | 27 | 41 | 0.22 | 216.82 | 0.00 | |
92 | Breast Disease | journal | 0.248 Q4 | 36 | 22 | 70 | 574 | 39 | 69 | 0.56 | 26.09 | 44.55 | |
91 | Bulletin du Cancer | journal | 0.276 Q4 | 44 | 181 | 534 | 5185 | 353 | 461 | 0.71 | 28.65 | 54.99 | |
90 | Pathogenesis | journal | 0.304 Q4 | 8 | 3 | 7 | 318 | 9 | 6 | 1.29 | 106.00 | 50.00 | |
89 | International Journal of Cancer Management | journal | 0.351 Q4 | 26 | 76 | 166 | 2311 | 157 | 146 | 1.04 | 30.41 | 37.72 | |
88 | South Asian Journal of Cancer | journal | 0.366 Q4 | 25 | 66 | 154 | 1237 | 108 | 90 | 0.70 | 18.74 | 27.54 | |
87 | Tumori | journal | 0.367 Q4 | 59 | 152 | 526 | 3805 | 458 | 509 | 0.91 | 25.03 | 46.99 | |
86 | In Vivo | journal | 0.382 | 72 | 134 | 398 | 2439 | 444 | 398 | 1.11 | 18.20 | 34.80 | |
85 | Journal of B.U.ON. | journal | 0.395 Q4 | 37 | 241 | 626 | 6545 | 736 | 550 | 1.28 | 27.16 | 36.73 | |
84 | Progress in Tumor Research | book series | 0.398 Q4 | 12 | 12 | 19 | 693 | 24 | 18 | 1.26 | 57.75 | 64.00 | |
83 | Cellular Oncology | journal | 0.433 Q3 | 44 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
82 | Molecular Therapy - Oncolytics | journal | 0.452 Q3 | 42 | 38 | 28 | 1858 | 39 | 27 | 1.39 | 48.89 | 33.33 | |
81 | Oncology Reviews | journal | 0.474 Q3 | 31 | 8 | 28 | 545 | 44 | 28 | 1.75 | 68.13 | 34.29 | |
80 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.504 Q3 | 56 | 269 | 390 | 3549 | 530 | 341 | 1.37 | 13.19 | 44.03 | |
79 | Experimental and Therapeutic Medicine (discontinued) | journal | 0.505 Q3 | 63 | 1053 | 2070 | 33717 | 3151 | 2070 | 1.50 | 32.02 | 39.87 | |
78 | International Journal of Biological Markers | journal | 0.512 Q3 | 47 | 40 | 174 | 1599 | 237 | 166 | 1.55 | 39.98 | 42.91 | |
77 | Oncology Research and Treatment | journal | 0.523 Q3 | 55 | 129 | 373 | 3215 | 441 | 323 | 1.19 | 24.92 | 36.53 | |
76 | ecancermedicalscience | journal | 0.540 Q3 | 47 | 111 | 316 | 4059 | 466 | 316 | 1.52 | 36.57 | 39.76 | |
75 | Oncology Letters | journal | 0.547 Q3 | 81 | 1527 | 2762 | 48215 | 4634 | 2756 | 1.57 | 31.57 | 37.99 | |
74 | Molecular Medicine Reports | journal | 0.646 Q3 | 86 | 1428 | 3278 | 51485 | 6168 | 3278 | 1.86 | 36.05 | 41.01 | |
73 | Hematological Oncology | journal | 0.658 Q3 | 54 | 33 | 152 | 911 | 242 | 135 | 1.46 | 27.61 | 39.11 | |
72 | Human Cell | journal | 0.661 Q3 | 44 | 24 | 69 | 700 | 128 | 63 | 1.96 | 29.17 | 27.40 | |
71 | Cancer Biomarkers | journal | 0.717 Q3 | 54 | 112 | 218 | 4158 | 479 | 213 | 2.40 | 37.13 | 40.76 | |
70 | Pathology and Oncology Research | journal | 0.719 Q3 | 61 | 119 | 401 | 3563 | 758 | 386 | 1.78 | 29.94 | 41.36 | |
69 | Infectious Agents and Cancer | journal | 0.748 Q3 | 47 | 58 | 145 | 2676 | 278 | 143 | 1.87 | 46.14 | 40.14 | |
68 | Future Oncology | journal | 0.752 Q3 | 90 | 298 | 864 | 13928 | 1627 | 781 | 1.90 | 46.74 | 35.15 | |
67 | Anticancer Research | journal | 0.769 Q3 | 136 | 925 | 2556 | 25431 | 5321 | 2551 | 2.07 | 27.49 | 30.16 | |
66 | Clinical and Translational Oncology | journal | 0.774 Q3 | 61 | 162 | 429 | 5624 | 951 | 414 | 2.35 | 34.72 | 42.64 | |
65 | Journal of Oral Pathology and Medicine | journal | 0.778 Q3 | 95 | 123 | 348 | 4366 | 795 | 344 | 2.22 | 35.50 | 44.77 | |
64 | Japanese Journal of Clinical Oncology | journal | 0.896 Q3 | 95 | 189 | 644 | 5167 | 1374 | 576 | 2.03 | 27.34 | 21.12 | |
63 | Oncology Reports | journal | 0.935 Q3 | 115 | 850 | 2192 | 32626 | 6231 | 2192 | 2.82 | 38.38 | 38.97 | |
62 | European Journal of Cancer, Supplement | journal | 0.942 Q3 | 29 | 1 | 86 | 146 | 102 | 71 | 2.43 | 146.00 | 33.33 | |
61 | Oncology | journal | 0.962 Q3 | 107 | 101 | 322 | 3129 | 849 | 312 | 2.50 | 30.98 | 31.55 | |
60 | Experimental Hematology and Oncology | journal | 0.992 Q3 | 42 | 29 | 77 | 1291 | 253 | 74 | 3.19 | 44.52 | 42.61 | |
59 | Cancer Genomics and Proteomics | journal | 0.996 Q3 | 50 | 49 | 89 | 2502 | 231 | 89 | 2.12 | 51.06 | 41.85 | |
58 | Leukemia Research | journal | 0.997 Q3 | 96 | 178 | 768 | 5709 | 1873 | 683 | 2.49 | 32.07 | 43.95 | |
57 | Familial Cancer | journal | 1.015 Q2 | 67 | 85 | 247 | 3370 | 554 | 242 | 1.85 | 39.65 | 54.17 | |
56 | Leukemia and Lymphoma | journal | 1.040 Q2 | 102 | 481 | 1674 | 13312 | 2755 | 1031 | 1.62 | 27.68 | 41.55 | |
55 | International Journal of Hyperthermia | journal | 1.041 Q2 | 98 | 109 | 263 | 4907 | 1028 | 258 | 3.41 | 45.02 | 30.36 | |
54 | Cancer Treatment and Research | journal | 1.056 Q2 | 65 | 65 | 131 | 4811 | 469 | 125 | 3.77 | 74.02 | 28.57 | |
53 | Cancer Cell International | journal | 1.071 Q2 | 80 | 83 | 371 | 3643 | 1246 | 370 | 2.97 | 43.89 | 45.14 | |
52 | Targeted Oncology | journal | 1.081 Q2 | 59 | 75 | 128 | 3460 | 407 | 124 | 3.04 | 46.13 | 38.46 | |
51 | Cancer Gene Therapy | journal | 1.098 Q2 | 99 | 66 | 233 | 2394 | 770 | 226 | 3.51 | 36.27 | 36.18 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®